Global Breast Lesion Localization Devices Market Poised for Growth is expected to reach US$ 554.9 Million by 2032 Driven by Rising Breast Cancer Risks and Technological Advancements | FMI

Posted on 2024-05-07 by Future Market Insights in Healthcare // 0 Comments

Breast Lesion Localization Devices Market

The global breast lesion localization devices market is projected to witness steady growth, reaching an estimated value of US$ 325.5 million by 2022 and growing at a CAGR of 5.5% by 2032, and the Breast lesion localization devices market is expected to reach US$ 554.9 Million by the end of 2032. This surge is primarily driven by the increasing prevalence of breast cancer and the growing adoption of advanced localization technologies.

Lifestyle Factors Heighten Breast Cancer Risk:

The report highlights a concerning trend – lifestyle choices significantly impact breast cancer risk. Factors like obesity, excessive alcohol consumption, and hormone therapy can elevate cancer development. Studies reveal that even moderate alcohol intake can increase risk by 7-10%, underlining the importance of preventative measures.

Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-3396

Advanced Localization Techniques Drive Market Growth:

The growing demand for minimally invasive and precise surgical procedures creates a significant opportunity for the breast lesion localization market. Advanced localization technologies offer the potential for simpler, more efficient breast surgeries, benefiting both radiologists and surgeons. This paves the way for new market entrants and technological advancements in this crucial medical field.

Key Opportunities for Breast Lesion Localization Devices Manufacturers:

Rising Demand: Early detection of breast cancer is crucial, and these devices are increasingly used for this purpose.
Limited Competition: Currently, only a few manufacturers dominate the market, leaving room for new entrants.
Growing Breast Cancer Rates: Breast cancer incidence is rising, particularly in developing countries and urban areas.
Increased Awareness: Initiatives like Breast Cancer Awareness Programmes (BCAP) are raising awareness about the disease and the importance of early detection.
Larger Patient Pool: Rising populations and growing disposable income in many regions will lead to a larger pool of potential patients.

Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-3396

Competitive Landscape:

Major players are concentrating on developing and introducing innovative detection tools for breast cancer. Established entities in the field are tailoring their strategies towards specific female demographics and pursuing strategic mergers and acquisitions to fortify their position in the cancer devices market.

In January 2020, Merit Medical Systems unveiled The TEMNO Elite Biopsy System, boasting enhanced reliability and novel features aimed at delivering superior soft tissue samples and complete procedural control. It also includes a patient-safety feature to mitigate complications, especially during lung biopsies.
In December 2021, BD (Becton, Dickinson, and Company), a prominent global medical technology corporation, disclosed its acquisition of Tissuemed, Ltd., a privately held company headquartered in Leeds, England.

Similarly, recent advancements in breast lesion localization device techniques, pertaining to various companies, have been meticulously monitored by the team at Future Market Insights, detailed in their comprehensive report.

Key Companies Profiled:

Merit Medical Systems
BD
ARGON MEDICAL
Hologic, Inc.
Endomagnetics Ltd.
MatekMedikal
Sirius Medical Systems B.V.
Izi Medical Products, LLC
Molli Surgical Inc
Elucent Medical
Intramedical Imaging
Isoaid
Vigeosrl
Medax Medical Devices
MDL SRL
BPB Medica
Sterylab S.R.L.
Tsunami Medical Srl
Laurane® Medical LLC
Biomedical Srl

Request Purchase Now: https://www.futuremarketinsights.com/checkout/3396

Key Market Segments Covered in Breast Lesion Localization Devices Industry Research:

By Technique:

Wire Localization
Non-Wire Localization
Radar Reflector Localization
Magnetic seed Localization
RFID Tag Localization
Radioisotope Localization

By Application:

Breast Biopsy
Breast Lumpectomy

By End User:

Hospitals
Ambulatory Surgical Centres
Specialty Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick